US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.160
  • -0.002-1.17%
Close Jan 7 16:00 ET
  • 0.167
  • +0.007+4.38%
Pre 04:07 ET
13.46MMarket Cap-0.53P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioLine Rx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 792.000K--
--2024/Q4-- / 7.718M--
Nov 25, 20242024/Q34.943M / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 792.000K--
--2024/Q4-- / 7.718M--
Nov 25, 20242024/Q34.943M / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--

Unlock Free Earnings Estimates

BioLine Rx Earnings Reports

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 7 10:19 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 25, 2024 07:12 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 21, 2024 06:54 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 19, 2024 16:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data